Published in Health Business Week, October 12th, 2007
Nanobiosym, and its commercial partner Nanobiosym Diagnostics, have been privately developing Gene-RADAR(R), a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism. The company's vision is to give patients worldwide real-time access to their own...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.